Sponsored by:

Molecular Imaging: Page 419

Dual-head gamma camera increases breast lesion detection
By Kate Madden Yee
In what they believe is the first clinical study conducted using a dual-head configuration of a molecular breast imaging system, researchers at the Mayo Clinic in Rochester, MN, explored whether the use of this kind of system would increase the sensitivity of this modality.
November 27, 2008
2008 11 21 12 31 42 882 Figure 4 Thumb
IsoRay taps VP
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has appointed Anthony Pasqualone as vice president of business development in charge of sales.
November 23, 2008
Proton therapy reduces bone marrow toxicity compared with IMRT
By Edward Susman
Tighter control of how much radiation is focused on a tumor and how much affects adjacent structures appears to result in less bone marrow toxicity among patients treated with proton beam therapy, when compared with conventional intensity-modulated radiation therapy (IMRT).
November 23, 2008
Adenosine stress DECT equivalent to SPECT, MRI
By Eric Barnes
A new power combo consisting of adenosine stress and dual-energy CT (DECT) is delivering diagnostic accuracy equivalent to stress/rest cardiac MRI and nuclear perfusion (SPECT) for detecting perfusion defects, according to research presented at the American Heart Association meeting in New Orleans.
November 20, 2008
2008 11 17 12 19 23 893 Ruzsics thumb 11 08
IBA's interim Q3 report shows mixed results
By AuntMinnie.com staff writers
Sales are up more than 50% for the first nine months of 2008 for radiopharmaceutical firm Ion Beam Applications (IBA), but the bottom line is expected to take a hit.
November 18, 2008
Dilon partners with Terason
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies and Terason will combine their respective technologies in molecular breast imaging and ultrasound.
November 17, 2008
Dual-time-point FDG-PET/CT improves breast imaging accuracy
By Kate Madden Yee
Recent study results suggest that dual-time-point imaging with acquisition in the prone position improves PET/CT accuracy in patients with suspected breast cancer over single-time-point PET/CT. However, for lesions smaller than 10 mm, MRI shows higher sensitivity and should be preferred, according to the researchers.
November 17, 2008
2008 11 17 15 20 23 842 Figure4 B Thumb
ART posts revenue gain in Q3
By AuntMinnie.com staff writers
Optical molecular imaging developer ART Advanced Research Technologies credits its transition to a direct distribution model for a gain in revenues in the third quarter.
November 16, 2008
PET, PiB support cognitive reserve hypothesis in Alzheimer's
By Wayne Forrest
A new study has found that people with more education appear to score higher on cognitive tests, despite having evidence of brain plaques associated with Alzheimer's disease. Researchers used the PET radiotracer carbon-11-labeled Pittsburgh Compound B (C-11 PiB) to image fibrillar beta-amyloid pathology in vivo.
November 13, 2008
Cardiolite use dropped in September
By AuntMinnie.com staff writers
A new market research report indicates that use of the Cardiolite radiopharmaceutical from Lantheus Medical Imaging dropped 9% in September compared to the previous year, but the agent still has a double-digit lead in market share.
November 12, 2008
Physician vacations affect IsoRay revenue in Q1
By AuntMinnie.com staff writers
Medical isotope developer IsoRay posted lower revenues for its first quarter.
November 12, 2008
Molecular Insight reports Q3 financials
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals announced financial results for its third-quarter and nine-month periods.
November 12, 2008
Previous Page
Page 419 of 612
Next Page